Efficacy of knee tape in the management of osteoarthritis of the knee: Blinded randomised controlled trial
ABSTRACT To test the hypotheses that therapeutic taping of the knee improves pain and disability in patients with osteoarthritis of the knee and that benefits remain after stopping treatment.
Randomised single blind controlled trial with three intervention arms (therapeutic tape, control tape, and no tape) of three weeks' duration and three week follow up.
Outcome assessment was performed in a university based laboratory. Taping interventions were applied by eight physiotherapists in metropolitan private practice.
87 patients with symptoms of knee osteoarthritis as defined by the American College of Rheumatology.
Primary outcome measure was pain as measured by visual analogue scale and participant perceived rating of change. Secondary measures of pain and disability included the Western Ontario and MacMaster Universities osteoarthritis index, knee pain scale, and the SF-36.
The therapeutic tape group reported a greater reduction in pain on all primary outcomes than either of the other two groups. A significant association was evident between intervention and change in pain at three weeks (P=0.000), with 73% (21/29) of the therapeutic tape group reporting improvement compared with 49% (14/29) of the control tape group and 10% (3/29) of the no tape group. Significantly greater improvement in pain and disability was observed on most secondary outcomes in the therapeutic tape group compared with the no tape group. Benefits of therapeutic tape were maintained three weeks after stopping treatment.
Therapeutic knee taping is an efficacious treatment for the management of pain and disability in patients with knee osteoarthritis.
- SourceAvailable from: Jian Pang
[Show abstract] [Hide abstract]
- "Some studies reveal that serum prostaglandin E2 (PGE2), interleukin-1 (IL-1), and interleukin-6 (IL-6) were decreased, while í µí»½-endorphin (í µí»½- EP) was increased in OA patients after using TCHPs  . (2) They have a slight fixation effect and could help patients overcome fear of pain as taping  . (3) The way of dispelling " cold evil, " removing " dampness evil, " and activating blood circulation might possibility have an impact on the immune and neurochemical systems to improve TCM syndrome . "
ABSTRACT: Objective. The aim of this study is to systematically evaluate the evidence whether traditional Chinese herbal patches (TCHPs) for osteoarthritis (OA) are effective and safe and analyze their medication patterns. Methods. A systematic literature search was performed using all the possible Medical Subject Headings (MeSH) and keywords from January 1979 to July 2013. Both randomized controlled trials (RCTs) and observational studies were included. Estimated effects were analyzed using mean difference (MD) or relative risk (RR) with 95% confidence intervals (CI) and meta-analysis. Results. 86 kinds of TCHPs were identified. RCTs and controlled clinical trials (CCTs) which were mostly of low quality favored TCHPs for local pain and dysfunction relief. TCHPs, compared with diclofenac ointment, had significant effects on global effectiveness rate (RR = 0.50; 95% CI (0.29, 0.87)). Components of formulae were mainly based on the compounds "Xiao Huo Luo Dan" (Minor collateral-freeing pill) and "Du Huo Ji Sheng Tang" (Angelicae Pubescentis and Loranthi decoction). Ten kinds of adverse events (AEs), mainly consisting of itching and/or local skin rashes, were identified after 3-4 weeks of follow-up. Conclusions. TCHPs have certain evidence in improving global effectiveness rate for OA; however, more rigorous studies are warranted to support their use.Evidence-based Complementary and Alternative Medicine 01/2014; 2014:343176. DOI:10.1155/2014/343176 · 1.88 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: A 55-year-old asymptomatic woman, who is 5 years postmenopausal, is concerned about osteoporosis, since her mother had a hip fracture at the age of 70 years. The patient has no personal history of fractures and has never taken corticosteroids. She does not smoke but does drink one to two glasses of wine a day. Her weight is 105 lb (48 kg), and her height is 62 in. (1.6 m); she has a body-mass index (the weight in ki- lograms divided by the square of the height in meters) of 19.2. Measurements of bone mineral density with the use of dual-energy x-ray absorptiometry show T scores of −1.7 at the spine and −1.5 at the femoral neck, findings that are consistent with osteope- nia. What should you advise?
Article: This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. Osteoarthritis of the Knee